Hubei Biocause Pharmaceutical (000627) — Cash Flow-to-Debt Ratio
Hubei Biocause Pharmaceutical (000627) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2023, meaning its operating cash flow of CN¥276.06 Million could theoretically repay 0% of its total liabilities (CN¥272.50 Billion) in one year. See free cash flow generation of Hubei Biocause Pharmaceutical to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hubei Biocause Pharmaceutical Cash Flow-to-Debt Ratio (2001–2023)
Historical debt coverage capacity for Hubei Biocause Pharmaceutical across 18 annual periods. Also explore Hubei Biocause Pharmaceutical (000627) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year debt coverage analysis for Hubei Biocause Pharmaceutical. For market capitalisation and broader financial context, see 000627 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | 0.04x | CN¥9.53 Billion | CN¥268.30 Billion | ▲ +20.0% |
| 2022 | 0.03x | CN¥7.52 Billion | CN¥254.00 Billion | ▲ +60.8% |
| 2021 | 0.02x | CN¥4.17 Billion | CN¥226.43 Billion | ▼ -82.4% |
| 2020 | 0.10x | CN¥21.42 Billion | CN¥204.81 Billion | ▼ -37.5% |
| 2019 | 0.17x | CN¥28.60 Billion | CN¥170.92 Billion | ▲ +70.0% |
| 2018 | 0.10x | CN¥14.98 Billion | CN¥152.24 Billion | ▲ +2492.8% |
| 2017 | 0.00x | CN¥431.58 Million | CN¥113.71 Billion | ▲ +115.8% |
| 2016 | -0.02x | CN¥-2.34 Billion | CN¥97.48 Billion | ▲ +67.8% |
| 2015 | -0.07x | CN¥-46.73 Million | CN¥625.50 Million | ▼ -141.3% |
| 2013 | 0.18x | CN¥130.53 Million | CN¥720.71 Million | ▲ +1.8% |
| 2012 | 0.18x | CN¥93.79 Million | CN¥527.37 Million | ▲ +24.7% |
| 2011 | 0.14x | CN¥66.95 Million | CN¥469.47 Million | ▼ -76.2% |
| 2010 | 0.60x | CN¥224.58 Million | CN¥374.25 Million | ▲ +132.1% |
| 2007 | 0.26x | CN¥118.56 Million | CN¥458.52 Million | ▼ -10.5% |
| 2006 | 0.29x | CN¥128.19 Million | CN¥443.66 Million | ▲ +111.8% |
| 2005 | 0.14x | CN¥48.66 Million | CN¥356.70 Million | ▼ -13.0% |
| 2004 | 0.16x | CN¥56.07 Million | CN¥357.41 Million | ▼ -4.9% |
| 2001 | 0.16x | CN¥37.30 Million | CN¥226.09 Million | — |